- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Cynapsus Therapeutics Inc+ Add to Watchlist
CYNAF:US0.4153 USD 0.0173 4.35%
As of 20:10:00 ET on 06/14/2013.
Company Profile for Cynapsus Therapeutics Inc (CYNAF)
Cynapsus Therapeutics, Inc. researches and develops pharmaceuticals. The Company researches treatments for Parkinson's disease, neuropathic pain associated with multiple sclerosis and cancer, and nausea and vomiting and appetite stimulation.
Cynapsus Therapeutics Inc
Key Executives for Cynapsus Therapeutics Inc (CYNAF)
|Anthony J GiovinazzoPresident/CEO||Andrew Michael WilliamsCFO/COO|
|Nathan BrysonChief Scientific Officer|